ES2626501T3 - D-psicosa 3-epimerasa mutante con estabilidad térmica mejorada, y producción continua de D-psicosa utilizando la misma - Google Patents
D-psicosa 3-epimerasa mutante con estabilidad térmica mejorada, y producción continua de D-psicosa utilizando la misma Download PDFInfo
- Publication number
- ES2626501T3 ES2626501T3 ES12826072.6T ES12826072T ES2626501T3 ES 2626501 T3 ES2626501 T3 ES 2626501T3 ES 12826072 T ES12826072 T ES 12826072T ES 2626501 T3 ES2626501 T3 ES 2626501T3
- Authority
- ES
- Spain
- Prior art keywords
- psychosa
- epimerase
- amino acid
- variant
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090001066 Racemases and epimerases Proteins 0.000 title description 10
- 102000004879 Racemases and epimerases Human genes 0.000 title description 10
- 238000010924 continuous production Methods 0.000 title description 2
- 150000001413 amino acids Chemical group 0.000 claims abstract description 79
- 229940024606 amino acid Drugs 0.000 claims abstract description 26
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 22
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 20
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 19
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 15
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229960000310 isoleucine Drugs 0.000 claims abstract description 14
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000012634 fragment Substances 0.000 claims abstract description 12
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 10
- 239000004474 valine Substances 0.000 claims abstract description 10
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 21
- 229930091371 Fructose Natural products 0.000 claims description 20
- 239000005715 Fructose Substances 0.000 claims description 20
- 239000013604 expression vector Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 238000003259 recombinant expression Methods 0.000 claims description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 10
- 235000001014 amino acid Nutrition 0.000 abstract description 23
- 235000018417 cysteine Nutrition 0.000 abstract 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 37
- 108090000790 Enzymes Proteins 0.000 description 37
- 230000000694 effects Effects 0.000 description 23
- 102220536709 Hemoglobin subunit epsilon_I33V_mutation Human genes 0.000 description 19
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 14
- 239000000243 solution Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000002255 enzymatic effect Effects 0.000 description 8
- 230000003993 interaction Effects 0.000 description 7
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 125000003118 aryl group Chemical group 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000006911 enzymatic reaction Methods 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 235000010413 sodium alginate Nutrition 0.000 description 5
- 239000000661 sodium alginate Substances 0.000 description 5
- 229940005550 sodium alginate Drugs 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 241000186216 Corynebacterium Species 0.000 description 4
- 241000672609 Escherichia coli BL21 Species 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 238000000302 molecular modelling Methods 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 description 2
- 108030002100 D-tagatose 3-epimerases Proteins 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000021472 generally recognized as safe Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 102200082884 rs33959855 Human genes 0.000 description 2
- 102200161838 rs62638195 Human genes 0.000 description 2
- 102220072507 rs794729056 Human genes 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010016275 Fear Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 239000007990 PIPES buffer Substances 0.000 description 1
- 241000208465 Proteaceae Species 0.000 description 1
- 241001508466 Pseudomonas cichorii Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000191043 Rhodobacter sphaeroides Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 241000883281 [Clostridium] cellulolyticum H10 Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002390 cell membrane structure Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 150000002231 fructose derivatives Chemical class 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003520 lipogenic effect Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229940055835 triptone Drugs 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- -1 xylitol Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
- C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/24—Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y501/00—Racemaces and epimerases (5.1)
- C12Y501/03—Racemaces and epimerases (5.1) acting on carbohydrates and derivatives (5.1.3)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110084712A KR101203856B1 (ko) | 2011-08-24 | 2011-08-24 | 열 안정성이 향상된 사이코스 에피머화 효소 변이체 및 이를 이용한 사이코스의 연속적 생산 |
| KR20110084712 | 2011-08-24 | ||
| PCT/KR2012/006637 WO2013027999A2 (ko) | 2011-08-24 | 2012-08-21 | 열 안정성이 향상된 사이코스 에피머화 효소 변이체 및 이를 이용한 사이코스의 연속적 생산 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2626501T3 true ES2626501T3 (es) | 2017-07-25 |
Family
ID=47565145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12826072.6T Active ES2626501T3 (es) | 2011-08-24 | 2012-08-21 | D-psicosa 3-epimerasa mutante con estabilidad térmica mejorada, y producción continua de D-psicosa utilizando la misma |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9217166B2 (OSRAM) |
| EP (2) | EP3192867A1 (OSRAM) |
| JP (1) | JP6043354B2 (OSRAM) |
| KR (1) | KR101203856B1 (OSRAM) |
| CN (1) | CN104160023B (OSRAM) |
| DK (1) | DK2749645T3 (OSRAM) |
| ES (1) | ES2626501T3 (OSRAM) |
| HR (1) | HRP20170813T1 (OSRAM) |
| HU (1) | HUE035316T2 (OSRAM) |
| IN (1) | IN2014CN01614A (OSRAM) |
| PL (1) | PL2749645T3 (OSRAM) |
| PT (1) | PT2749645T (OSRAM) |
| RS (1) | RS56088B1 (OSRAM) |
| SI (1) | SI2749645T1 (OSRAM) |
| WO (1) | WO2013027999A2 (OSRAM) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101318422B1 (ko) * | 2013-04-09 | 2013-10-15 | 주식회사 삼양제넥스 | D-사이코스 에피머화 효소, 및 이를 이용하는 사이코스 생산방법 |
| KR101455624B1 (ko) | 2013-04-12 | 2014-10-28 | 주식회사한국야쿠르트 | 기능성 희귀당 사이코스의 생산능을 지닌 신규 클로스트리디움 볼티에 유래의 사이코스-3-에피머화 효소 및 이를 이용한 사이코스 생산방법 |
| KR101455759B1 (ko) * | 2013-04-23 | 2014-10-28 | 씨제이제일제당(주) | 사이코스 에피머화 효소 변이체 및 이를 이용한 사이코스의 제조 방법 |
| WO2015032761A1 (en) * | 2013-09-03 | 2015-03-12 | Roquette Freres | Improved variant of d-psicose 3-epimerase and uses thereof |
| EP2843044A1 (en) * | 2013-09-03 | 2015-03-04 | Roquette Frères | Improved variant of D-psicose 3-epimerase and uses thereof |
| KR101539097B1 (ko) * | 2013-12-26 | 2015-07-23 | 주식회사 삼양제넥스 | 사이코스 에피머화 효소를 암호화 하는 폴리뉴클레오타이드, 및 이를 이용하는 사이코스 생산방법 |
| KR101473918B1 (ko) | 2014-05-28 | 2014-12-17 | 대상 주식회사 | 사이코스 에피머화 효소, 이의 제조방법 및 이를 이용한 사이코스의 제조방법 |
| KR101577147B1 (ko) * | 2014-10-01 | 2015-12-11 | 경상대학교산학협력단 | 사이코스의 생산 방법 |
| KR101607633B1 (ko) | 2014-10-21 | 2016-04-11 | 주식회사 삼양사 | 코리네박테리움속 균주를 이용한 사이코스 생산방법 |
| US10240140B2 (en) | 2014-10-30 | 2019-03-26 | Samyang Corporation | Expression system for psicose epimerase and production for psicose using the same |
| KR101754060B1 (ko) | 2014-11-06 | 2017-07-05 | 경상대학교산학협력단 | 사이코스의 제조 방법 |
| KR102044957B1 (ko) * | 2014-12-31 | 2019-11-14 | 주식회사 삼양사 | 사이코스의 제조방법 |
| KR101677368B1 (ko) * | 2015-04-02 | 2016-11-18 | 씨제이제일제당 (주) | 신규 프로모터 및 이의 용도 |
| KR102087396B1 (ko) | 2015-11-16 | 2020-03-10 | 주식회사 삼양사 | 과당-함유 기질로부터 사이코스를 생산하는 방법 |
| KR101807507B1 (ko) | 2015-12-23 | 2017-12-12 | 씨제이제일제당(주) | D-사이코스 3-에피머화 효소 및 염을 포함하는 d-사이코스 제조용 조성물 및 이를 이용한 d-사이코스의 제조 방법 |
| KR101723007B1 (ko) | 2016-02-29 | 2017-04-04 | 씨제이제일제당(주) | 고순도 d-사이코스를 제조하는 방법 |
| CN105821027B (zh) * | 2016-04-01 | 2023-11-21 | 南京朗奈生物技术有限公司 | 一种3-差向异构酶的用途 |
| KR101946157B1 (ko) * | 2016-07-29 | 2019-02-11 | 씨제이제일제당 (주) | D-타가토스 전환 활성이 향상된 헥수론산 c4-에피머화 효소 변이체 및 이를 이용한 d-타가토스의 제조 방법 |
| CN106148311B (zh) * | 2016-09-12 | 2019-06-21 | 上海立足生物科技有限公司 | 一种d-阿洛酮糖-3-差向异构酶的突变体及其应用 |
| US11174475B2 (en) | 2016-11-16 | 2021-11-16 | Cj Cheiljedang Corporation | D-psicose 3-epimerase and method for preparing D-psicose using the same |
| CN108239633B (zh) * | 2016-12-26 | 2023-05-05 | 上海立足生物科技有限公司 | 一种催化活性得到提高的d-阿洛酮糖-3-差向异构酶的突变体及其应用 |
| EP3565892A4 (en) | 2017-01-06 | 2020-10-07 | Greenlight Biosciences, Inc. | ACELLULAR SUGAR PRODUCTION |
| KR102319955B1 (ko) * | 2018-01-24 | 2021-10-29 | 마쓰다니가가꾸고오교가부시끼가이샤 | 열안정성이 향상된 케토스 3－에피머라제 |
| KR102439295B1 (ko) | 2018-11-30 | 2022-09-02 | 씨제이제일제당 주식회사 | D-사이코스 결정 및 이의 제조 방법 |
| CN110396513B (zh) * | 2019-07-19 | 2022-01-11 | 天津科技大学 | 一种d-阿洛酮糖-3-差向异构酶的突变体及其应用 |
| CN110684762B (zh) * | 2019-11-12 | 2021-03-19 | 南京工业大学 | 一种d-阿洛酮糖-3-差向异构酶突变体及其编码基因、重组载体、重组菌株和应用 |
| CN111019928B (zh) * | 2019-12-11 | 2022-08-16 | 吉林中粮生化有限公司 | D-阿洛酮糖3-差向异构酶的编码基因、载体、重组细胞以及它们的应用 |
| KR102254411B1 (ko) | 2019-12-19 | 2021-05-24 | 대상 주식회사 | 알룰로스 에피머화 효소 변이체, 이의 제조방법 및 이를 이용한 알룰로스의 제조방법 |
| WO2021199445A1 (en) * | 2020-04-03 | 2021-10-07 | Rensselaer Polytechnic Institute | Method for producing sulfated polysaccharide and method for producing paps |
| KR102448351B1 (ko) | 2020-04-27 | 2022-09-28 | 대상 주식회사 | 알룰로스 에피머화 효소 변이체, 이의 제조방법 및 이를 이용한 알룰로스의 제조방법 |
| JP7348457B2 (ja) | 2020-06-03 | 2023-09-21 | ティアンゴン バイオテクノロジー（ティアンジン）カンパニー，リミテッド | プシコース３－エピメラーゼミュータント、それを発現するための遺伝子工学菌、その固定化酵素及び固定化方法 |
| CN111793616B (zh) * | 2020-08-07 | 2022-04-12 | 天津科技大学 | 一种差向异构酶的突变体及其应用 |
| KR102682846B1 (ko) * | 2021-11-19 | 2024-07-08 | 대상 주식회사 | 열 안정성이 우수한 알룰로스 에피머화 효소 변이체, 이의 제조방법 및 이를 이용한 알룰로스의 제조방법 |
| KR20240108871A (ko) * | 2022-12-30 | 2024-07-10 | 주식회사 삼양사 | 알룰로스 3-에피머화 변이 효소 및 이의 용도 |
| WO2025111274A2 (en) * | 2023-11-20 | 2025-05-30 | Novozymes A/S | Epimerase variants and polynucleotides encoding same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100744479B1 (ko) * | 2005-06-01 | 2007-08-01 | 씨제이 주식회사 | 사이코스 에피머화 효소에 의한 사이코스의 생산 방법 |
| GB0512150D0 (en) * | 2005-06-15 | 2005-07-20 | Scottish Crop Res Inst | Production of L-ascorbic acid |
| KR20110035805A (ko) | 2009-09-30 | 2011-04-06 | 씨제이제일제당 (주) | 사이코스-에피머화 효소의 고정화 및 이를 이용한 사이코스의 제조방법 |
-
2011
- 2011-08-24 KR KR1020110084712A patent/KR101203856B1/ko active Active
-
2012
- 2012-08-21 IN IN1614CHN2014 patent/IN2014CN01614A/en unknown
- 2012-08-21 DK DK12826072.6T patent/DK2749645T3/en active
- 2012-08-21 HR HRP20170813TT patent/HRP20170813T1/hr unknown
- 2012-08-21 PL PL12826072T patent/PL2749645T3/pl unknown
- 2012-08-21 EP EP17153617.0A patent/EP3192867A1/en not_active Withdrawn
- 2012-08-21 HU HUE12826072A patent/HUE035316T2/en unknown
- 2012-08-21 US US14/240,647 patent/US9217166B2/en active Active
- 2012-08-21 CN CN201280052112.0A patent/CN104160023B/zh active Active
- 2012-08-21 RS RS20170604A patent/RS56088B1/sr unknown
- 2012-08-21 JP JP2014527066A patent/JP6043354B2/ja active Active
- 2012-08-21 EP EP12826072.6A patent/EP2749645B1/en active Active
- 2012-08-21 SI SI201230996T patent/SI2749645T1/sl unknown
- 2012-08-21 WO PCT/KR2012/006637 patent/WO2013027999A2/ko not_active Ceased
- 2012-08-21 PT PT128260726T patent/PT2749645T/pt unknown
- 2012-08-21 ES ES12826072.6T patent/ES2626501T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RS56088B1 (sr) | 2017-10-31 |
| HUE035316T2 (en) | 2018-05-02 |
| CN104160023A (zh) | 2014-11-19 |
| DK2749645T3 (en) | 2017-08-21 |
| JP6043354B2 (ja) | 2016-12-14 |
| SI2749645T1 (sl) | 2017-08-31 |
| KR101203856B1 (ko) | 2012-11-21 |
| IN2014CN01614A (OSRAM) | 2015-05-08 |
| EP2749645B1 (en) | 2017-04-26 |
| HRP20170813T1 (hr) | 2017-08-11 |
| WO2013027999A9 (ko) | 2013-07-11 |
| EP2749645A2 (en) | 2014-07-02 |
| US20140199732A1 (en) | 2014-07-17 |
| CN104160023B (zh) | 2017-03-29 |
| US9217166B2 (en) | 2015-12-22 |
| WO2013027999A3 (ko) | 2013-05-10 |
| EP3192867A1 (en) | 2017-07-19 |
| EP2749645A4 (en) | 2015-06-10 |
| WO2013027999A2 (ko) | 2013-02-28 |
| JP2014525244A (ja) | 2014-09-29 |
| PT2749645T (pt) | 2017-07-28 |
| PL2749645T3 (pl) | 2017-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2626501T3 (es) | D-psicosa 3-epimerasa mutante con estabilidad térmica mejorada, y producción continua de D-psicosa utilizando la misma | |
| ES2614891T3 (es) | Inmovilización de psicosa-epimerasa y método para producir D-psicosa utilizando la misma | |
| ES2656287T3 (es) | Mutante de psicosa epimerasa y método para preparar psicosa mediante su uso | |
| US8802393B2 (en) | Arabinose isomerase expressed from Corynebacterium genus and tagatose manufacturing method by using it | |
| ES2424240T3 (es) | Microorganismo recombinante con capacidad de utilizar sacarosa como fuente de carbono | |
| ES3010384T3 (en) | Fructose to allulose conversion using a burkholderia enzyme | |
| CN105637089A (zh) | D-阿洛酮糖3-差向异构酶的改进的变体及其用途 | |
| WO2013005800A1 (ja) | アルスロバクター グロビホルミスの生産する酵素 | |
| BRPI0706981A2 (pt) | seqüências de nucleotìdeos, vetor, células hospedeiras transformadas por vetor, proteìna codificada, dextrana sacarase truncada, proteìna de fusão, método de preparação de dextrana sacarase, método de produção de dextranas e/ou isomalto-oligossacarìdeos, dextrana, isomalto-oligossacarìdeos, composição, composição farmacêutica ou alimetìcia, composiçaõ de texturização, uso de dextrana sacarase, uso de dextrana e uso de dextrana ou imo | |
| ES2726941T3 (es) | Moléculas de ácidos nucleicos que codifican una dextrano-sacarasa que cataliza la síntesis de dextrano que porta ramificaciones de tipo alfa-1,2 osídicas | |
| AU2001234090B2 (en) | Novel inulin synthase and process for producing inulin by using the same | |
| CN116656658A (zh) | 一种海藻酸裂解酶突变体 | |
| CN115011622B (zh) | 一种d-阿洛酮糖3-差向异构酶突变体的筛选方法及其应用 | |
| ES2314088T3 (es) | Una isomerasa termoestable y su uso, en particular para producir tagatosa. | |
| US20100041106A1 (en) | Recombinant gras strains expressing thermophilic arabinose isomerase as an active form and method of preparing food grade tagatose by using the same | |
| WO2025036155A1 (zh) | 岩藻糖及其中间体的制备方法及其应用 | |
| Jebur et al. | Partial purification and characterization of L-arabinose isomerase produced from local isolate of Bacillus subtilis AH1. |